RxDoctor Payments Data

Jasmine Jacobs

Psychiatric/Mental Health · Decatur, ALNPI 1891204152

Payments from drug & device makers

$2,816in general payments, 2019–2025

Across 156 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$403
  • AbbVie$302
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$296
  • Alkermes, Inc.$271
  • Bausch Health US, LLC$226
  • Takeda Pharmaceuticals U.S.A., Inc.$192
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$2,76798%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,816 in reported general payments places this provider in the 70th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Medicare billing

Part B allowed, 2024
$18,673
Medicare patients
43
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate26$93,899
VraylarCariprazine Hcl25$37,221
Abilify MaintenaAripiprazole11$30,952
Paliperidone ErPaliperidone26$4,251
Lurasidone Hcl43$2,721
Clozapine78$2,641
Olanzapine47$1,718
Divalproex Sodium ErDivalproex Sodium50$1,029
Atomoxetine Hcl19$1,010
Quetiapine Fumarate146$863
Duloxetine Hcl28$849
Lamotrigine73$726
Risperidone16$569
Aripiprazole34$502
Trazodone Hcl63$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$129$93,89926 claims
AbbVieVraylar$302$37,22125 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$403$30,95211 claims
Almatica Pharma LLCSertraline Hcl$20$40758 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Decatur

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →